ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,836, issued on Nov. 25, was assigned to LG CHEM Ltd. (Seoul, South Korea).
"Sphingosine-1-phosphate receptor agonist, preparation method therefor, and pharmaceutical composition containing same as active ingredient" was invented by Seung Yup Paek (Daejeon, South Korea), Deok Seong Park (Daejeon, South Korea) and Sang Yong Hong (Daejeon, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel compound represented by Formula 1, functioning as a sphingosine-1-phosphate receptor agonist useful for treating autoimmune disorders, a preparation method therefor, a pharmaceutical composition containing the same as ...